TRAVERE THERAPEUTICS
Travere Therapeutics is advancing therapeutic candidates for rare disorders in nephrology, hepatology and metabolism; sponsoring no-cost genetic testing aimed at improving the diagnostic odyssey for children born with cholestasis; partnering with patient advocacy organizations to meet the diverse needs of patients and their families; and ensuring broad access and education for its FDA-approved therapies.
TRAVERE THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2008-02-07
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.travere.com
Total Employee:
101+
Status:
Active
Contact:
(646) 564-3680
Email Addresses:
[email protected]
Total Funding:
942 M USD
Technology used in webpage:
Apple Mobile Web Clips Icon WordPress LetsEncrypt Amazon SSL By Default Mobile Non Scaleable Content IPv6 ReCAPTCHA Google Wordpress Plugins
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
ArrePath
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
F2G
F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-10-22 | Orphan Technologies | Orphan Technologies acquired by Travere Therapeutics | 517 M USD |
| 2014-02-13 | Manchester Pharmaceuticals | Manchester Pharmaceuticals acquired by Travere Therapeutics | N/A |
Investors List
Athyrium Capital Management LP
Athyrium Capital Management LP investment in Post-IPO Debt - Travere Therapeutics
Athyrium Capital Management LP
Athyrium Capital Management LP investment in Post-IPO Equity - Travere Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2014-07-31 | Perlara | Travere Therapeutics investment in Seed Round - Perlara | 2.8 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-04 | Travere Therapeutics Appoints Jula Inrig, M.D., as Chief Medical Officer |
Official Site Inspections
http://www.travere.com Semrush global rank: 1.58 M Semrush visits lastest month: 15.02 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Travere Therapeutics"
Who We Are | Travere
Careers | Travere Therapeutics
Travere employees work cross-functionally, collaborating with colleagues throughout the organization, and serve on committees such as our internal diversity council.See details»
Home - Travere Medical Affairs
Welcome to Travere Therapeutics Global Medical Affairs At Travere Therapeutics Global Medical Affairs, we are dedicated to sharing …See details»
Travere Therapeutics - Investor Relations
At Travere Therapeutics, we are in rare for life We come together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease.See details»
Travere Therapeutics - Events & Presentations
Travere Therapeutics First Quarter 2025 Earnings Results Investor Fact Sheet Open Event Link, PDF file, May 1, 2025, (opens in new window) Travere Therapeutics Fourth Quarter and Full Year 2024 Earnings ResultsSee details»
Travere Therapeutics - News
Jul 11, 2025 Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) View PDF , Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4), June 12, 2025, (opens in new window) June 11, 2025 Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 15th International Podocyte ConferenceSee details»
Travere Therapeutics - LinkedIn
Travere Therapeutics | 35,794 followers on LinkedIn. In rare for life. | Our mission is to identify, develop and deliver life-changing therapies to people living with rare disease. #InRareForLife ...See details»
Travere TotalCare - Support for Patient and …
Travere TotalCare provides patients and Healthcare Professionals with information on insurance coverage, financial assistance programs, …See details»
Travere Therapeutics Management Team | Org Chart - RocketReach
Travere Therapeutics employs 436 employees. The Travere Therapeutics management team includes Eric Dube (CEO), Angela Giannantonio (Chief People Officer), and Elizabeth Reed (Senior Vice President, General Counsel and Secretary).See details»
Log In - travereevents.com
Travere Therapeutics employee? Log in hereForgot your password? Set a new oneSee details»
Medical Information - Travere Medical Affairs
About Medical Information at Travere This site is an online medical resource that provides access to scientific, clinical, and trial information about Travere products and related information. The information provided is intended for US healthcare professionals only to answer unsolicited medical questions, but it is not intended to provide medical advice.See details»
Travere Therapeutics - Crunchbase Company Profile & Funding
Aug 16, 2013 Travere discovers and develops drugs for the treatment of catastrophic diseases that are debilitating and often life-threatening.See details»
Travere Therapeutics Overview | SignalHire Company Profile
The annual revenue of Travere Therapeutics varies between 100M and 500M. Total funding of the company - $68.9M. To connect with Travere Therapeutics employee register on SignalHire. Organization Website travere.com Social Links Phone Number 8889697879 Travere Therapeutics industries Biotech, Pharmaceuticals, Biotechnology Headquarters LocationSee details»
Leadership & Board | Travere
Board Diversity Travere is committed to the principles of workforce development, diversity and inclusion adopted by the Biotechnology Innovation Organization. Learn more about our DEI commitment.See details»
Travere Therapeutics - Profiles & Contacts - Crunchbase
Travere discovers and develops drugs for the treatment of catastrophic diseases that are debilitating and often life-threatening.See details»
Member Spotlight: Travere Therapeutics - Biocom California
June 15, 2023 Member Spotlight: Travere Therapeutics Travere Therapeutics Advocates for Patients and Health Equity While Finding Treatments for Rare Diseases Eric Dube is no stranger to overcoming adversity. When he was 18 years old in the early ‘90s, he came out as a gay man—at a time when the HIV epidemic was at its height.See details»
Contact - Travere Medical Affairs
The purpose of this Travere Therapeutics Medical Affairs website is to support healthcare professionals with scientific information. This website is also a channel for US healthcare professionals to submit questions or connect with Travere Therapeutics US …See details»
Travere Therapeutics: Culture | LinkedIn
Travere Therapeutics provides competitive benefits and a highly collaborative hybrid working environment (Flex Forward) that values equity, diversity and inclusion.See details»
Travere Therapeutics - Governance - Governance Documents
News Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote Events & PresentationsSee details»
Careers - travere.wd1.myworkdayjobs.com
Travere provides comprehensive total rewards offerings that demonstrate our commitment as a diverse, equitable, people-centric, and pay-for-performance organization.See details»